ANTX · An2 Therapeutics, Inc.
SELL 86%
78
Total trades
17
Insiders on record
86%
Avg confidence
SELL
Signal direction
Recent insider trades
| Date | Insider | Action | Type | Value | Confidence |
|---|---|---|---|---|---|
| Nov 4, 2025 | Joshua M Eizen | SELL | Open-market sale | 3.2K | 0.82 |
| Nov 4, 2025 | Stephen David Prior | SELL | Open-market sale | 872.1 | 0.87 |
| Jun 2, 2025 | Eric Easom | BUY | Open-market purchase | 10.7K | 0.93 |
| May 30, 2025 | Braden Michael Leonard | SELL | Open-market sale | 429.3K | 0.93 |
| May 28, 2025 | Margaret M Fitzpatrick | BUY | Open-market purchase | 10.1K | 0.83 |
| May 28, 2025 | Braden Michael Leonard | SELL | Open-market sale | 218K | 1.00 |
| Jan 3, 2025 | Lucy Day | SELL | Open-market sale | 4K | 0.93 |
| Jan 3, 2025 | Sanjay Chanda | SELL | Open-market sale | 4K | 0.89 |
| Jan 3, 2025 | Stephen David Prior | SELL | Open-market sale | 2.7K | 0.88 |
| Jan 3, 2025 | Joshua M Eizen | SELL | Open-market sale | 13K | 0.83 |
An2 Therapeutics, Inc. has 78 total insider trades on record. Sign up to see the full history, track records, and evidence trails.
Want alerts when insiders trade ANTX?
Sign up free to get notified, see the full trade history, and track insider conviction over time.
Sign up freeInsiderTrack aggregates publicly available SEC Form 4 filings. Data is provided for informational purposes only and should not be construed as investment advice. Always do your own research before making investment decisions.